Article Details

U.S. FDA rejects AstraZeneca treatment for chronic nasal condition | Reuters

Retrieved on: 2022-03-14 07:31:48

Tags for this article:

Click the tags to see associated articles and topics

U.S. FDA rejects AstraZeneca treatment for chronic nasal condition | Reuters. View article details on hiswai:

Excerpt

AstraZeneca Plc said on Monday the U.S. Food and Drug Administration (FDA) rejected its asthma medicine, Fasenra, for treatment of chronic ...

Article found on: www.reuters.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up